Early monitoring for detection of antituberculous drug-induced hepatotoxicity
Chang Min Lee, Sang Soo Lee, Jeong Mi Lee, Hyun Chin Cho, Wan Soo Kim, Hong Jun Kim, Chang Yoon Ha, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee
Korean J Intern Med. 2016;31(1):65-72.   Published online 2015 Dec 28     DOI: https://doi.org/10.3904/kjim.2016.31.1.65
Citations to this article as recorded by Crossref logo
Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials
Lina Tao, Xiaoyu Qu, Yue Zhang, Yanqing Song, Si-xi Zhang
Canadian Journal of Gastroenterology and Hepatology.2019; 2019: 1.     CrossRef
The role of regular liver function monitoring in antituberculosis drug-induced liver injury
Tien-En Chang, Yi-Shin Huang, Wei-Juin Su, Chin-Lin Perng, Yi-Hsiang Huang, Ming-Chih Hou
Journal of the Chinese Medical Association.2019; 82(7): 535.     CrossRef
Management of adverse reactions to first-line tuberculosis antibiotics
Sowmya Nagarajan, Paul Whitaker
Current Opinion in Allergy and Clinical Immunology.2018; 18(4): 333.     CrossRef
Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population
Yu Wang, Xi Xiang, Shou-Quan Wu, Guo Chen, Miao-Miao Zhang, Ming-Gui Wang, Feng-Juan Wang, Andrew J. Sandford, Jian-Qing He
Infection, Genetics and Evolution.2017; 51: 198.     CrossRef
Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity
Eunyoung Heo, Deog Kyeom Kim, So Hee Oh, Jung-Kyu Lee, Ju-Hee Park, Hee Soon Chung
Tuberculosis and Respiratory Diseases.2017; 80(3): 265.     CrossRef
Occult hepatitis B virus infection: clinical implications in tuberculosis treatment
C. Trigo, P. E. A. A. do Brasil, M. J. M. Costa, L. de Castro
Journal of Viral Hepatitis.2016; 23(12): 1027.     CrossRef
A Severe Hepatotoxicity by Antituberculosis Drug, and its Recovery in Oriental Hospital
Chang-Gue Son
Journal of Korean Medicine.2016; 37(2): 119.     CrossRef